XML 45 R28.htm IDEA: XBRL DOCUMENT v3.8.0.1
BALANCES AND TRANSACTIONS WITH KEY OFFICERS AND CERTAIN SHAREHOLDERS
 12 Months Ended
Dec. 31, 2017
Disclosure of transactions between related parties [abstract]  
BALANCES AND TRANSACTIONS WITH KEY OFFICERS AND CERTAIN SHAREHOLDERS
NOTE 22: -
BALANCES AND TRANSACTIONS WITH KEY OFFICERS AND CERTAIN SHAREHOLDERS

a.
2017 shareholders information refers to Monsanto which, to the best of the Company’s knowledge, hold approximately 6.4% of the Company's ordinary shares and is also a major customer (see also Notes 5, 21(c)).

b.
Balances:
 
Balance at December 31, 2017:
 
   
Key officers
    
Certain shareholder
  
             
Receivables
  
$
-
    
$
337
  
Other payables
  
$
468
    
$
-
  
 
Balance at December 31, 2016:
 
   
Key officers
    
Certain shareholder
  
             
Receivables
  
$
-
    
$
283
  
Other payables
  
$
285
    
$
-
  


c.
Benefits to directors:

   
Year ended December 31,
  
   
2017
    
2016
    
2015
  
                   
Compensation to directors not employed by the Company or on its behalf
  
$
329
    
$
322
    
$
371
  
                         
Number of directors received the above compensation by the Company
    
6
      
9
      
8
  
 
d.          Salary and Benefits to key officers:

   
Year ended December 31,
  
   
2017
    
2016
    
2015
  
                   
Salary and related benefits
  
$
1,673
    
$
1,714
    
$
1,849
  
Share-based compensation
    
959
      
1,467
      
2,254
  
                         
   
$
2,632
    
$
3,181
    
$
4,103
  
Number of people that received salary and benefits
    
7
      
10
      
8
  

e.
Transactions:
 
For the year ended December 31, 2017
 
   
Key officers
    
Certain shareholder
  
             
Revenues
  
$
-
    
$
(2,247
)
Cost of revenues
    
141
      
(948
)
Research and development expenses
    
1,061
      
-
  
Business development expenses
    
547
      
-
  
General and administrative expenses
    
883
      
-
  
                 
   
$
2,632
    
$
(3,195
)
 
For the year ended December 31, 2016
 
   
Key officers
    
Certain shareholders
  
             
Revenues
  
$
-
    
$
(5,058
)
Cost of revenues
    
104
      
(782
)
Research and development expenses
    
1,286
      
-
  
Business development expenses
    
710
      
-
  
General and administrative expenses
    
1,081
      
-
  
                 
   
$
3,181
    
$
(5,840
)
 
For the year ended December 31, 2015
 
   
Key officers
    
Certain shareholders
  
             
Revenues
  
$
-
    
$
(10,095
)
Cost of revenues
    
544
      
(656
)
Research and development expenses
    
1,194
      
-
  
Business development expenses
    
874
      
-
  
General and administrative expenses
    
1,491
      
-
  
                 
   
$
4,103
    
$
(10,751
)